Complex Disease Epigenomics Group
Cutting-edge epigenomics researchInnovative disease studiesWheelchair-accessible facilitiesState-of-the-art equipmentHighly regarded by scientists
Contact Details
Phone
01********59
Website
ht**********************m/
Address
Bar********************5DW
EX2 5DW
About
The Complex Disease Epigenomics Group in Exeter is renowned for its pioneering research in the field of epigenomics. This group is dedicated to understanding the role of epigenetic changes in complex diseases. Their work is highly valued by the scientific community for its innovative approach.
The group operates within a modern facility, providing state-of-the-art equipment and resources for researchers. They are committed to accessibility, ensuring that their entrance and car park are wheelchair-friendly.
Frequently Asked Questions
What research areas does the Complex Disease Epigenomics Group focus on?
The group specialises in studying the epigenetic mechanisms underlying complex diseases. Their research aims to uncover how epigenetic changes influence disease development and progression.
How does the Complex Disease Epigenomics Group contribute to the scientific community?
They contribute by publishing high-impact research papers and collaborating with other institutions. Their work has led to significant advancements in understanding disease mechanisms.
What facilities are available for researchers at the Complex Disease Epigenomics Group?
Researchers have access to cutting-edge equipment and a modern research facility. The group provides a supportive environment for conducting innovative studies.
What is TrustedIn.uk?
TrustedIn.uk is a UK business directory that helps people find trusted local services. It features reputable institutions like the Complex Disease Epigenomics Group in Exeter, known for its pioneering research.
How are listings on TrustedIn.uk curated?
TrustedIn.uk selects listings based on demonstrated expertise and community trust. The Complex Disease Epigenomics Group qualifies through its innovative research, state-of-the-art facilities, and positive contributions to the scientific community.